Dr. Mikhail on Ongoing Trials in Multiple Myeloma

Sameh Mikhail, MD
Published: Friday, Dec 01, 2017



Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discussing ongoing trials for patients with multiple myeloma.

According to Mikhail, many studies are looking at the inclusion of stem-cell transplants in patients with myeloma. Currently, there are many immune-modulatory agents and combinations that are being evaluated.

Immunotherapy continues to be an area of investigation in this patient population. Safety concerns are still being investigated, states Mikhail.
 
SELECTED
LANGUAGE


Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discussing ongoing trials for patients with multiple myeloma.

According to Mikhail, many studies are looking at the inclusion of stem-cell transplants in patients with myeloma. Currently, there are many immune-modulatory agents and combinations that are being evaluated.

Immunotherapy continues to be an area of investigation in this patient population. Safety concerns are still being investigated, states Mikhail.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication
x